ILAG (ILAG) Stock Price & Analysis
ILAG (ILAG) fell 3.72% to USD 3.45 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
ILAG last closed at USD 3.59; the session ranged USD 3.34–3.6 on volume of 12,617 shares. Market capitalization is $7.17M, with a 52-week range of USD 2.04–9.56 (NCM). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 3.45 |
|---|---|
| Change | ▼ 3.72% (down) |
| Previous Close | USD 3.59 |
| Open | USD 3.6 |
| Day Range | USD 3.34 – 3.6 |
| 52-Week Range | USD 2.04 – 9.56 |
| Volume | 12,617 shares |
| Market Cap | $7.17M |
| Exchange | NCM |
Technical Analysis (ILAG)
Nexqual's technical model rates ILAG "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.22 (neutral) |
| vs SMA50 | Below (USD 3.59) |
| MACD | -0.01 (negative) |
Analyst Ratings (ILAG)
Wall Street analysts rate ILAG "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (ILAG)
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (ILAG)
| Total Revenue | $4.49M |
|---|---|
| Revenue Growth (YoY) | -27.90% |
| Gross Margin | +2.89% |
| Operating Margin | -511.54% |
| Profit Margin | +0.00% |
| ROE | -221.18% |
| Debt / Equity | 37.85 |
| Current Ratio | 1.97 |
| Total Cash | $645,939 |
| Total Debt | $1.84M |
| Free Cash Flow | $-5.82M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (ILAG)
Nexqual rates ILAG's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Critical — Revenue -28% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $646K cash vs $2M debt |
| Cash Flow | Weak — FCF negative: -$6M, burning cash |
| Efficiency | Critical — ROE -221%, ROA -90.3% |
Ownership (ILAG)
| Insider Ownership | +52.48% |
|---|---|
| Institutional Ownership | +0.13% |
| Shares Outstanding | 2.08M |
| Float | 986,446 |
| Short % of Float | +4.19% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (ILAG)
ILAG is led by Yu Bong Lau (age 46), CEO & Chairman of the Board, per Nexqual as of July 25, 2026 at 02:21 UTC.
| CEO & Chairman of the Board | Yu Bong Lau (age 46) |
|---|---|
| COO & Director | Yu Bun Lau (age 43) |
| CTO & Director | Po Wang Hui (age 73) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MEGL | Magic Empire Global Limited | USD 1.15 | ▲ 0.17% |
| PXMD | PaxMedica, Inc. | USD 0 | ▲ 0% |
| ATXG | Addentax Group Corp. | USD 3.7 | ▼ 2.63% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 4.28 | ▼ 2.17% |
| VRAX | Virax Biolabs Group Limited | USD 3.19 | ▼ 12.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.